Inclusion Criteria 1.Patient who was performed by use rigid cystoscopy size 22 Fr 2.Patient who was performed by use rigid cystoscopy size 22 Fr with tissue biopsy at bladder mucosa 3.Patient who was performed by use rigid cystoscopy size 22 Fr with ureteral insertion size 6 Fr 4.Femal and male patients age above 18 Yrs old Cystoscopy Entonox Pain
Conditions
Interventions
Blind Two Arm patient underwent Cystoscopy by use Enotonox inhalation every 15 min during performed Cystoscopy for evaluate pain score
,Blind Two Arm patient underwent Cystoscopy by use Oxygen inhal
Experimental Drug,Experimental Drug
Entonox (Oxygen and Nitrous Gas inhalation mixture),Oxygen inhalation
Sponsors
None listed
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patient who was performed with Rigid Cystoscopy for diagnosis (22 Fr Size) 2.Patient who was performed with Rigid Cystoscopy and bladder biopsy for diagnosis (22 Fr Size) 3.Patient who was performed with Rigid Cystoscopy and ureteral stent insertion (22 Fr for Rigid Cystoscopy and 6 Fr for ureteral stent)
Exclusion criteria
Exclusion criteria: 1.patient who refuse this project 2.History of lidocaine or nitrous mixture halation allergy 3.patient with impairing pain perception 4.patient with maxillofacial injury 5.patient with pneumothorax
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain Control every 15 minutes during cystoscopy and after immediate cystoscopy and 15 minutes after that Numeric rating Scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Side Effect of Enotonox 1 Year Questionnaire interview | — |
Countries
Thailand
Contacts
Public ContactTanawat Lohityothin
Faculty of medicine Thammasart University Hospital
Outcome results
None listed